Eli Lilly Finances World Health Org (WHO) promoting psychotropic drugs

Eli Lilly Finances World Health Org (WHO) promoting psychotropic drugs

Sat, 20 Aug 2005

The credibility of the World Health Organization (WHO) is in doubt since its financial ties to Eli Lilly and Johnson and Johnson.

The reach of Big Pharma is indeed all-encompassing. NOTHING written in the mental health field by professional associations, such as the Americaqn Psychiatric Association, or government agencies, such as the National Institute of Mental Health, or “non-profit” NGOs such as the Mental Health Association, or even the WHO is to be trusted because all of these organizations are under the influence of Big Pharma.

The Final Report–“Nations for Mental Health”–issued by the WHO Mental Health Policy and Service Development, Department of Mental Health and Substance Dependence (2002), was underwritten by Eli Lilly and Johnson & Johnson.

See: http://www.who.int/mental_health/media/en/400.pdf

Acknowledgements

WHO gratefully acknowledges the financial support of Nations for Mental Health by the Eli Lilly and Company Foundation, the Johnson and Johnson Corporate Contributions Europe Committee, the Government of Italy, the Government of Japan, the Government of Norway, the Government of Australia and the Brocher Foundation.

The introduction states:

Nations for Mental Health was to pursue the following goals:

1. To raise awareness of the people and governments of the world to the effects of mental health problems and substance abuse on the psychosocial well­being of the world’s underserved populations.

2. To stimulate innovative approaches to the promotion of mental health and the prevention and control of mental disorders.

3. To generate the human capital able to lead innovation in the mental health promotion and care provision.

4. To promote service development at country level through technical demonstration projects.

A three-step approach was envisaged to create a process leading to put mental health in the political agenda. The first step was to increase the general awareness of the importance of mental health through a series of key high profile events to focus public attention. Second, it was planned that efforts would be devoted to building the will of the key political authorities to participate. Third, and finally, efforts were directed towards securing political commitments by decision-makers (e.g., legislative measures, policy undertakings, and performance of specific initiatives in favour of mental health, such as a campaign to destigmatize mental disorders). Alliances with the scientific community and policy­makers were seen as achievable in the context of demonstration projects and through the effects of awareness-raising efforts.”

Nations for Mental Health is, therefore, a covert promotional marketing tool masquerading as an objective credible source of information.

**Reminder: Eli Lilly and Johnson & Johnson are not charities.

Lilly and J & J are in business to increase drug sales and profits. They manufacture blockbuster drugs such as: Prozac, Cymbalta, Straterra, Zyprexa (Lilly) and Risperdal (J & J).

When pharmaceutical companies provide provides “gifts” to individual physicians, government or Not fror profit organizations–they do so for but one purpose only: That purpose is to promote their drugs so that sales will increase. Drug manufacturers love to fund “anti-stigma” campaigns–thereby ensuring an ever increasing customer base.

Every one who accepts financial support from a pharmaceutical company–no matter what the stated “educational” goal–becomes a promoter of the company’s drugs–whether the receipients acknowledge that fact or not.

Contact: Vera Hassner Sharav
212-595-8974